Apax raises $750 million in commitments for first generation credit funds

Apax
  • Credit funds build on Apax’s 50-year track record to invest in attractive credit opportunities
  • Sector-led investment strategy with flexible mandate to invest across the capital structure
  • Credit strategy fully integrated into global Apax platform, leveraging Apax’s deep sector knowledge built over decades
  • c.40% already invested and committed across the credit funds

 

Apax Partners LLP (“Apax”) today announces that it has successfully raised c.$750m for the first generation of dedicated Apax Credit Funds.

The strength of the fundraise demonstrates the solid growth and success of Apax’s credit platform. Apax advised funds have invested in credit for over a decade, including advising London listed Apax Global Alpha on its credit investment portfolio. In total, Apax has advised on approximately 90 credit investments since 2013, and total credit capital advised by Apax stands at approximately $1.5bn.

Apax’s credit strategy is fully integrated into the wider Apax platform. The dedicated credit team works hand-in-hand with Apax’s private equity teams to meet the increasing demand for flexible, long-term private credit solutions. With their focus on the four core Apax sectors – Tech, Services, Healthcare and Internet/Consumer – the Apax Credit Funds leverage Apax’s deep sector knowledge built over decades. The Credit strategy is highly synergistic with Apax’s private equity strategies, targeting the types of businesses that are well known to Apax through its private equity sector insights. Apax Credit Funds have a flexible mandate, with the ability to invest across the capital structure. They are geared towards providing the right capital solutions in partnership with companies and management teams.

Mitch Truwit, Co-CEO, Apax, commented: “The Apax Credit strategy is a growing platform with a truly differentiated approach to credit investing, and we are thankful for the support of our limited partners as well as their confidence in our team. We see Credit as an important extra arrow in our quiver. This strategy allows us to diversify the way in which we can support companies identified through our private equity sub-sector diligence, while also providing our investors with another way to access compelling returns.”

This fundraising announcement follows an active year for the Apax Credit Funds. Over the last twelve months, the funds have deployed capital in 19 investments.

 

ENDS

 

About Apax Credit and Apax

Established 10 years ago, Apax Credit is fully integrated into the wider Apax Platform, fully leveraging Apax’ 50 years of experience. Like the Apax Private Equity Funds, the Apax Credit Fund focuses on investments in four core sectors: Tech, Services, Healthcare and Internet/Consumer, and within each they identify attractive sub-sectors where they can offer differentiated propositions to companies, their management teams, and wider stakeholders. The Apax Credit strategy benefits from a flexible mandate, allowing the team to focus on the credit solutions that offer the best fit in each case. For further information, please visit: https://www.apax.com/create/strategies/apax-credit/

Apax Partners LLP (“Apax”) is a leading global private equity advisory firm. For 50 years, Apax has worked to inspire growth and ideas that transform businesses. The firm has raised and advised funds with aggregate commitments of more than $65 billion. The Apax Funds invest in companies across four global sectors of Tech, Services, Healthcare, and Internet/Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For further information about Apax, please visit www.apax.com.

GLOBAL MEDIA CONTACT

Katarina Sallerfors

t: +44 20 7872 6300

Luke Charalambous

t: +44 20 7872 6300

Categories: News

EQT Private Equity to sell LimaCorporate, one of the global leaders in joint replacement solutions

eqt

EQT Private Equity, together with its co-shareholders, to sell LimaCorporate to NYSE-listed Enovis Corporation

Under EQT Private Equity’s ownership, LimaCorporate has grown to be one of the leading European orthopaedic companies. EQT and LimaCorporate worked together to further empower surgeons with innovative orthopaedic implants that improve patient outcomes

Today, LimaCorporate’s products are sold in 49 countries across the globe with more than 130,000 implants delivered every year, with a strong focus on product innovation helping surgeons restore the “eMotion of Motion” in patients

EQT is pleased to announce that the EQT VII fund (“EQT Private Equity” or “EQT”), together with its co-shareholders, have agreed to sell LimaCorporate (the “Company”) to Enovis Corporation. With this transaction, LimaCorporate becomes part of the NYSE-listed Enovis Corporation in a strategic combination that creates a global leader in the orthopaedic industry.

Founded in 1945 by the Lualdi family and headquartered in San Daniele del Friuli, Italy, LimaCorporate is a global orthopaedic implant manufacturer with a heritage of innovation, reflected in its industry leading know-how in additive manufacturing, such as its proprietary Trabecular Titanium (“TT”) technology. The Company focuses on shoulder, knee and hip prostheses with a portfolio that includes one of the first modular shoulder systems in the world, the SMR, the Delta hip cup family, and the Physica system knee.

EQT has supported LimaCorporate in the expansion of its product portfolio primarily through in-house innovation and the advancement of its 3D printing capabilities. It has invested to solidify its core offering and increase manufacturing capacity in the face of rapidly growing demand, while further developing talent to execute on the Company’s market expansion, with accelerated global growth. In 2022, the Company reached revenues of EUR 249 million and it will continue to bring critical innovation to surgeons and patients as part of Enovis Corporation.

Matteo Thun, Partner within EQT Private Equity’s Advisory Team, said, “LimaCorporate is a true example of sophisticated engineering and technology designed to empower surgeons and to improve patients’ life. EQT is proud to have been part of the Company’s journey and I want to thank the management team and all the employees of LimaCorporate, who work enthusiastically every day to bring life-changing products to patients around the world. It is exciting to see a global player like Enovis Corporation joining forces with LimaCorporate in such a strategic combination”.

Massimo Calafiore, CEO of LimaCorporate, said, “I am really proud of what the people of LimaCorporate have achieved over the years and I thank EQT for their partnership. The combination with Enovis Corporation is a key milestone in our journey and I am looking forward to seeing the combined Group continue to develop innovative products for surgeons and patients globally”.

The transaction is subject to customary conditions and approvals and is expected to close in early 2024.

EQT has been advised by Goldman Sachs as lead financial advisor, Morgan Stanley, Mediobanca, Latham & Watkins and PwC.

Contact
EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

About EQT
EQT is a purpose-driven global investment organization with EUR 224 billion in total assets under management (EUR 126 billion in fee-paying assets under management) within two business segments – Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia-Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.

More info: www.eqtgroup.com
Follow EQT on LinkedIn, Twitter, YouTube and Instagram

About LimaCorporate
LimaCorporate is a global orthopedic company, focused on digital innovation and patient-tailored hardware, which advances patient-centred care.  Its pioneering technological solutions are developed to empower surgeons, and to improve patient outcomes from joint replacement surgery.  Its primary focus is on providing reconstructive and custom-made orthopedic solutions to surgeons, enabling them to improve the quality of life of patients by restoring the joy of movement.

Headquartered in Italy, the company operates directly in over 20 countries around the world. LimaCorporate offers products ranging from large joint revision and primary implants, to complete extremities solutions, including fixation.

For additional information on the Company, please visit www.limacorporate.com

About Enovis Corporation
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.

For more information about Enovis, please visit www.enovis.com

Categories: News

Tags:

Anavo Therapeutics Strengthens Management Team

M Ventures

The company appoints industry veteran Shaun McNulty as Chief Scientific Officer and welcomes R&D expert Anna Quattropani as Senior Vice President of Chemistry & Non-Clinical Development

Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of phosphatase biology, announced the appointment of Shaun McNulty, DPhil, as Chief Scientific Officer (CSO) and the appointment of Anna Quattropani, PhD, as Senior Vice President of Chemistry and Non-Clinical Development. Dr. McNulty will oversee the implementation of Anavo’s strategy from discovery into clinical development and, together with Dr. Quattropani and Anavo’s management team, the continued design of Anavo’s first- and best-in-class phosphatase-targeting allosteric modulators.

“We are fortunate to welcome Anna and Shaun to the Anavo team at this stage of our company’s growth,” said Birgit Zech, PhD, Chief Executive Officer of Anavo Therapeutics. “Anna and Shaun’s industry knowledge and R&D experience will support Anavo’s progress in creating a proprietary portfolio of therapeutic programs and establishing a robust platform for phosphatase targeting across multiple indications.”

Shaun McNulty, DPhil, has more than 30 years of experience in the biopharma industry, with a focus on designing and developing therapeutics in oncology. He has served as Chief Scientific Officer at companies utilizing novel approaches in biology and chemistry, including Biosceptre, Inflection Biosciences and Awakn Life Sciences. He has led scientific R&D teams for companies such as Charles River, GSK, Pfizer and Syntaxin. Through his many roles, Dr. McNulty has supported the clinical development of Neurontin and Lyrica, obtained regulatory clearance for 5 drug candidates to enter the clinic, and identified and refined over 50 candidates for pre-clinical development. Dr. McNulty holds a DPhil in Biochemistry and Cell Biology and a BSc in Biochemistry from the University of York in the UK and performed post-doctoral research at the University of Cambridge on kinase-mediated neuronal cell signaling.

“Anna and Shaun’s industry knowledge and R&D experience will support Anavo’s progress in creating a proprietary portfolio of therapeutic programs and establishing a robust platform for phosphatase targeting across multiple indications.”

Birgit Zech, PhD, Chief Executive Officer of Anavo Therapeutics.

“Anavo’s IGNITE platform uniquely enables the rapid identification and development of therapeutics targeting phosphatases, initially thought to be undruggable targets,” said Dr. McNulty. “I am excited to join the Anavo team as we continue to accelerate our proprietary portfolio of programs targeting disease-relevant phosphatases toward clinical development and to build out our next-generation approach for phosphatase targeting.”

Anna Quattropani, PhD, joins Anavo with over 20 years of experience in medicinal chemistry and drug discovery. She has a successful track record designing multiple clinical candidates and driving them from discovery through clinical development. Dr. Quattropani has been working in diverse therapeutic areas, including neurodegenerative, inflammatory, autoimmune, and cardiovascular diseases, as well as women’s health. She has held senior leadership roles at Asceneuron and Draupnir and R&D roles at Serono and Merck KGaA. Dr. Quattropani is the inventor of several clinical molecules such as the O-GlcNAcase inhibitors ASN90 and ASN51 for neurodegenerative diseases and the oxytocin receptor antagonist Nolasiban. She obtained her PhD and MS in organic synthesis and organometallic chemistry at University of Geneva, Switzerland followed by postdoctoral training at the University of California, Irvine. Dr. Quattropani is the inventor of 49 patents and the author of 21 peer-reviewed publications.

“I am very proud to join Anavo’s outstanding team and help accelerate the discovery and development of phosphatase-targeting allosteric modulators to provide potential alternative therapeutic solutions for patients,” said Dr. Quattropani.

Anavo’s former CSO Gerhard Müller, PhD, joins the Scientific Advisory Board to continue contributing to the board’s drug discovery and development.

Categories: People

KKR appoints Kimberly A. Ross as new independent Director

KKR

NEW YORK–(BUSINESS WIRE)–KKR & Co. Inc. (NYSE: KKR) today announced that Kimberly A. Ross has been appointed to the Board of Directors of KKR & Co. Inc. (the “Company” and, together with its subsidiaries, “KKR”) effective September 20, 2023. Her appointment will bring the number of independent directors to ten out of a total of fourteen Board seats.

KKR Appoints Kimberly A. Ross as New Independent Director (Photo: Business Wire)

Ms. Ross is the former Chief Financial Officer of several public companies, including WeWork Inc., Baker Hughes Company, Avon Products, Inc., and Royal Ahold N.V.
The Company’s other independent directors include Adriane Brown (Managing Partner of Flying Fish Partners), Matthew Cohler (former General Partner at Benchmark), Mary Dillon (President and Chief Executive Officer of Foot Locker, Inc.), Arturo Gutiérrez Hernández (Chief Executive Officer of Arca Continental, S.A.B. de C.V.), Dane Holmes (Co-Founder, Chairman and Chief Executive Officer of Eskalera, Inc.), Xavier Niel (Founder and Chairman of the Board of Iliad SA), Patricia Russo (former Chief Executive Officer of Alcatel-Lucent), Robert Scully (former member of the Office of the Chairman of Morgan Stanley), and Evan Spiegel (Co-Founder and Chief Executive Officer of Snap Inc.).
About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

Contacts
Investor Relations:
Craig Larson
Tel: +1-877-610-4910 (U.S.) / +1-212-230-9410
investor-relations@kkr.com
Media:
Kristi Huller
Tel: +1-212-750-8300
media@kkr.com

Categories: People

Mr Lawrence Wong appointed as Deputy Chairman of the GIC Board

GIC

Singapore, September 25, 2023 – GIC announces the appointment of Mr Lawrence Wong, currently GIC Director, as Deputy Chairman. The appointment is effective 1 October 2023.

Mr Wong has been a GIC Director and Chairman of the Investment Strategies Committee (ISC) since 1 November 2018 and 7 July 2023 respectively. As Deputy Chairman, Mr Wong will assist the Chairman to lead the Board in overseeing GIC’s long-term asset allocation and portfolio performance.

Mr Wong is currently Singapore’s Deputy Prime Minister and Minister for Finance. He is the Chairman of the Monetary Authority of Singapore, and Chairman of Singapore Economic Development Board’s International Advisory Council. He is also a member of the Future Economy Council, the Research, Innovation and Enterprise Council and the National Research Foundation Board.

Categories: People

Eurazeo and ICAPITAL® announc eglobal partnership to widen access to Eurazeo’s PRivate Markets Opportunities for Wealth managers and their clients

No Comments
Eurazeo

Eurazeo will leverage iCapital’s cutting-edge technology and iCapital Marketplace to distribute Eurazeo’s suite of alternative offerings to Wealth Managers globally

 

Eurazeo, a leading global investment company with a diversified portfolio of €35 billion in assets under management, and iCapital1, the global fintech platform driving access to alternative investments for the wealth management industry, have today announced a partnership to increase Wealth Managers’ access to Eurazeo’s broad range of private markets opportunities.

Through this partnership, Eurazeo will leverage iCapital’s cutting-edge technology and iCapital Marketplace to support Eurazeo in distributing its suite of alternative offerings to Wealth Managers globally. The first launch available will be a feeder fund into Eurazeo’s new impact fund focused on Transition Infrastructure.

Eurazeo has a long-standing, 20-year track record of providing Wealth Managers and their high-net-worth clients with innovative investment solutions. Leveraging the technology and distribution of iCapital Marketplace, the partnership will support Eurazeo’s continued commitment to bring its broad suite of capabilities to Wealth Managers globally enabling them to build diversified portfolios for their clients.

Eurazeo has significant expertise across private equity, private debt, real estate and infrastructure strategies and is invested in around 600 companies. It launched a number of new products for private clients in 2023, highlighting its deep sector knowledge and its focus on delivering the best possible opportunities for its clients.

 

Luc Maruenda, Head of Wealth Solutions at Eurazeo, said:

“Addressing private individual investors and helping them broaden access to the private markets is part of our DNA and strategy. Based on our 20-year successful track record in France, we believe iCapital will be instrumental in replicating this strategy in Europe and beyond. With its leading technology and global positioning, iCapital was a natural choice to enhance the range of investment solutions for our Wealth Managers globally.

 

Marco Bizzozero, Head of International at iCapital, said:

“We are delighted to welcome Eurazeo, a leading global investment company with considerable private markets experience, to iCapital Marketplace to support Eurazeo in distributing its investment offering to Wealth Managers and their clients around the world. This partnership demonstrates that iCapital is the partner of choice for Asset Managers accessing the growing pool of private wealth as Wealth Managers increasingly seek to benefit from including private markets investments in a diversified portfolio for their private clients.”

Categories: News

Tags:

Fibbl raises €4 million to scale XR technologies in e-commerce, bridging the gap between physical and online stores

Industriefonden

Fibbl raises €4 million to scale XR technologies in e-commerce, bridging the gap between physical and online stores 

Swedish company Fibbl, a pioneer in 3D model production and XR (extended reality) technology for e-commerce, successfully closed a €4 million investment round. The round was led by Industrifonden, with support from business angels Pontus Lindwall, Göran and Henrik Garvner and John Wattin. The new funds will be utilized to boost go-to-market efforts, further cementing Fibbl’s position as a key player in the rapidly growing market.

E-commerce enterprises face significant challenges when implementing XR experiences at scale, with complex processes that require substantial time and up-front costs. Fibbl’s technology simplifies this journey by providing brands and retailers with on-demand access to consistent and unparalleled quality of 3D models, optimized for omnipresence in XR across platforms.

“We firmly believe in a future where the online product experience exceeds that of traditional brick-and-mortar stores and are thrilled to get the support from strong investors in bringing our vision to life,” said Henrik Arlestig, co-founder and CEO of Fibbl. “With our advanced XR technology and a scalable software-as-a-service business model, we are at the forefront of transforming the e-commerce landscape.”

Through seamless plug-and-play integration and easy onboarding, brands and retailers gain immediate access to 3D content and XR technologies, facilitating rapid adoption and improved shopping experiences for their end-customers. Fibbl’s agnostic and scalable technology can adapt to emerging technologies and extend beyond their current focus on sport and fashion products to various product verticals.

Caroline Wachtmeister, at Industrifonden, commented:  “As customers increasingly demand a comprehensive understanding of the products they purchase, Fibbl’s innovative solutions are poised to play a crucial role in shaping the future of online retail for the better. We are thrilled to support Fibbl in their mission to revolutionize e-commerce through the integration of 3D and XR technologies. With an exceptional team, Fibbl is well-positioned to capitalize on the immense potential of the market.”

Categories: News

Tags:

GBA Group expands range of toxicology services

Fields Group

Hamburg/Roßdorf, 20. September 2023. GBA Group is expanding its range of toxicology services for customers in the chemical, medical device and pharmaceutical industries with the acquisition of ICCR-Roßdorf GmbH (ICCR-Roßdorf) from investor FIELDS Group. This acquisition underlines GBA Group’s ambition to position itself broadly as an international life science service provider through targeted portfolio expansions and investment in leading CROs.

Today’s ICCR-Roßdorf GmbH (Institute for Competence Contract Research – Roßdorf) was founded in 1986 and has its headquarters with almost 100 employees in Roßdorf near Darmstadt. The focus of ICCR-Rossdorf is the investigation of the genotoxic potential of pharmaceuticals, agrochemicals, cosmetics and chemicals. For customers in the field of medical devices, the service portfolio is supplemented with modified protocols for the investigation of the effects of extracts.

Dr. Sabine Gorynia, Executive Vice President Pharma & Medical Devices, GBA Group, underlines the synergies resulting from the merger: “With more than 30 years of experience, one of the world’s leading Gentox providers enriches the portfolio and business network of GBA Group. We are pleased to further strengthen our growth in the preclinical area together with our colleagues from ICCR-Roßdorf and to be able to offer our national and international customers another important component in an even broader service portfolio.”

Dr. Markus Schulz, Managing Director of ICCR: “The constructive and open discussion in the run-up to the transaction showed that the closer cooperation between GBA Group and ICCR-Roßdorf offers great opportunities. This applies both to the broad use of the solutions and expertise we have developed in the toxicology field within the GBA Group and to joint projects in the development of innovative assays in new areas of application.”

 

About GBA Group

GBA Group is an international life science service company with more than 2,000 employees in 8 countries and a broad range of analytical, logistical and specialist services in the fields of pharmaceuticals, medical products, cosmetics, chemicals, food, drinking water and the environmental sustainability. The range of services offered by the GBA Group includes laboratory analytics, data management, special logistical services for clinical trials, as well as consulting services for private companies and public institutions in connection with their activities in the fields of research, product development, market development, and consumer protection. Through its work, the GBA Group makes a sustainable contribution to public health, the environment and society as a whole.

About FIELDS Group

FIELDS Group is an entrepreneurial, hands-on investor focused on developing businesses with potential. FIELDS invests in companies headquartered in the Benelux and DACH regions and achieves fundamental transformations with its team.

Categories: News

Tags:

Activa Capital sells its stake in Explore Group

Activa Capital

Activa Capital sells its stake in the capital of Explore Group, the leading provider of construction and
commercial project tender information, in favor of Intescia as part of a strategic alliance.
Founded in 1997 by Laurent Nicouleau and Philippe Raison, Explore Group has firmly established itself
as the foremost provider of information regarding tenders in the construction and commercial project
sector in France.

The acquisition of Explore Group will consolidate Intescia’s position with a unique portfolio of solutions
covering construction, real estate, business services, healthcare, and retail, serving over 20,000
customers and 100,000 users in Europe.

This recent transaction comes merely four years after Activa Capital’s initial commitment. During this
period, Explore Group has notably acquired 3 highly complementary companies, enabling the
expansion of its solution portfolio and distribution channels, reinforcing the verticalization of its
offerings, and consolidating its leadership in the real estate and construction sector.
« The alliance between the Intescia and Explore groups represents a unique opportunity to create the
European leader in BtoB business intelligence solutions based on a unique platform of brands and
services. This is the culmination of a project that began 25 years ago, accelerated by Activa Capital’s
support as part of our growth and development dynamic » said Laurent Nicouleau and Philippe Raison
founding directors of Explore.

« We are very proud to have supported the Explore Group during the 2019 primary LBO alongside the
founders and their team. With 3 acquisitions, Explore has achieved remarkable growth, doubling in size
over the period. We will continue to closely monitor this exciting industrial alliance, which is creating
the first European business intelligence platform based on AI. We wish all the best to the teams involved
in this new partnership.» added Christophe Parier and Alexandre Masson, Managing Partners of
Activa Capital.

Participants
Acquirers
Intescia: Yannick Dupuch, Damien Le Berre
Five Arrows : Younes Zemmouri, Victor de Tracy, Morgane Casalta, Lauriane Cadiou
Advisor to the acquirers
M&A: Amala Partners (Jean-Baptiste Marchand)
Transaction Services : Alvarez & Marsal (Frédéric Steiner, Simon Regard)

Lawyers: McDermott Will & Emery (Grégoire Andrieux, Fabrice Piollet)
Sellers
Activa Capital: Alexandre Masson, Christophe Parier, David Quatrepoint, Elliot Thiéblin
Management: Laurent Nicouleau, Philippe Raison
Advisors to the sellers
M&A: Bryan Garnier (Thibaut de Smedt, Stanislas de Gmeline, Jonathan Bohbot, Paul
Wertheimer, Théo Demeusoy)
Transaction Services: Iteraxon (Nicolas Bayle)
Lawyers Activa Capital: Hogan Lovells (Florian Brechon, Stéphane Huten, Shanna Hodara,
Guillaume Denis)
Lawyers founders: Fidal (Jean-François Yerle, Jironi Harivel)
About Explore Group
Explore Group is a leading player in B2B data intelligence with undisputed expertise in real estate and
construction. Building on 25 years of expertise, Explore Group is home to several brands including Explore,
the leading French provider for construction project intelligence, Wanao for public tender management,
Sendao for fully-outsourced tender submission and Codata, the leader in retail and commercial real estate
data. Explore Group operates from offices in France, Belgium and Morocco. www.explore.fr

About d’Activa Capital
Activa Capital is an independent private equity firm, owned by its partners, characterized by a proactive
build-up strategy. It currently manages more than €300 million on behalf of institutional investors by
investing in French SMEs and ETIs with high growth potential and an enterprise value of between €20 and
€100 million. Activa Capital assists them to accelerate their development and international presence. To find
out more about Activa Capital, visit www.activacapital.com

Press Contacts
Alexandre Masson Christophe Parier
Managing Partner Managing Partner
+33 1 43 12 50 12 +33 1 43 12 50 12
alexandre.masson@activacapital.com christophe.parier@activacapital.com

Categories: News

Tags:

Ship Spare Logistics and Global Transport Solutions join forces

FIrst Dutch

We are thrilled to announce that Ship Spare Logistics (SSL), previously a part of Burando Maritime Services and a member of the First Dutch of Companies, has been acquired by Global Transport Solutions (GTS). This strategic move brings together two industry leaders and sets the stage for a new era in marine spare parts logistics.

The union of SSL and GTS marks a significant milestone in the maritime industry. By combining their expertise, resources, and international networks, these companies are poised to deliver unparalleled service offerings. This synergy will enable them to meet the increasingly complex demands of the marine logistics sector efficiently.

Through the integration of cutting-edge technology and seamless service coordination, SSL and GTS aim to revolutionize the market. Their shared vision is to provide a disruptive and comprehensive logistics solution, streamlining the entire process from vendor to vessel. Clients can expect a streamlined and hassle-free experience thanks to the innovative solutions and deep industry knowledge that SSL and GTS bring to the table.

As part of the First Dutch group of companies, we proudly support Ship Spare Logistics on their transformative journey alongside Global Transport Solutions. This collaboration promises to create a logistics powerhouse within the maritime industry, setting new standards for excellence and customer satisfaction.

To learn more about this announcement, please click here.

Categories: News